Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SECUKINUMAB Cause Red cell distribution width increased? 63 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Red cell distribution width increased have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.

63
Reports of Red cell distribution width increased with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
4
Deaths
13
Hospitalizations

How Dangerous Is Red cell distribution width increased From SECUKINUMAB?

Of the 63 reports, 4 (6.3%) resulted in death, 13 (20.6%) required hospitalization, and 4 (6.3%) were considered life-threatening.

Is Red cell distribution width increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 63 reports have been filed with the FAERS database.

What Other Side Effects Does SECUKINUMAB Cause?

Drug ineffective (27,434) Psoriasis (21,976) Pain (15,244) Arthralgia (13,769) Fatigue (9,406) Psoriatic arthropathy (8,900) Pruritus (8,755) Malaise (8,570) Rash (8,023) Condition aggravated (7,536)

What Other Drugs Cause Red cell distribution width increased?

CLOZAPINE (439) METHOTREXATE (210) ALEMTUZUMAB (202) RITUXIMAB (198) PREDNISONE (178) PALBOCICLIB (171) ADALIMUMAB (144) METHYLPREDNISOLONE (123) ECULIZUMAB (110) TOCILIZUMAB (108)

Which SECUKINUMAB Alternatives Have Lower Red cell distribution width increased Risk?

SECUKINUMAB vs SELADELPAR LYSINE SECUKINUMAB vs SELEGILINE SECUKINUMAB vs SELENIUM SECUKINUMAB vs SELENIUM SULFIDE SECUKINUMAB vs SELEXIPAG

Related Pages

SECUKINUMAB Full Profile All Red cell distribution width increased Reports All Drugs Causing Red cell distribution width increased SECUKINUMAB Demographics